Clinical implications of telomerase activity and inactivation of the tumor suppressor gene p16 (CDKN2A) in head and neck cancer
Otolaryngol Pol
.
2000;54(3):291-5.
Authors
S Koscielny
1
,
R Dahse
,
J Sonntag
,
U Riese
,
C Theuer
,
M E Hofmann
,
F von Eggeling
,
U Claussen
,
E Beleites
,
G Ernst
,
W Fiedler
Affiliation
1
ENT-Department Friedrich-Schiller-University, Jena, Germany.
PMID:
10917055
No abstract available
MeSH terms
Disease Progression
Genes, Tumor Suppressor / genetics
Genes, p16 / genetics*
Head and Neck Neoplasms / enzymology*
Head and Neck Neoplasms / genetics*
Humans
Prognosis
Telomerase / genetics*
Telomerase / metabolism*
Substances
Telomerase